drugset / Trial / NCT07121192
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
RandomizedParallel-groupQuadruple-blindPrevention
Summary
"The purpose of this study is to assess the reactogenicity, safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults."
Timeline
- Start
- 2025-08-25
- Primary completion
- 2026-05-11
- Completion
- 2026-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK6479715A | Unknown | — | Intramuscular |
| Subject | GSK6479720A | Unknown | — | Intramuscular |